Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Daiichi Sankyo
McKinsey
Chubb
Accenture
Baxter
Merck
Cantor Fitzgerald
Colorcon

Generated: December 10, 2017

DrugPatentWatch Database Preview

Pentosan polysulfate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pentosan polysulfate sodium and what is the scope of pentosan polysulfate sodium patent protection?

Pentosan polysulfate sodium
is the generic ingredient in one branded drug marketed by Janssen Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for pentosan polysulfate sodium. Three suppliers are listed for this compound.

Pharmacology for pentosan polysulfate sodium

Ingredient-typeGlycosaminoglycans
Drug ClassGlycosaminoglycan
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Janssen PharmsELMIRONpentosan polysulfate sodiumCAPSULE;ORAL020193-001Sep 26, 1996RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pentosan polysulfate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen PharmsELMIRONpentosan polysulfate sodiumCAPSULE;ORAL020193-001Sep 26, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Novartis
Johnson and Johnson
Citi
Cipla
UBS
US Army
Merck
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot